IP Library Patent Application 18013380
Patent Application
App. No. 18/013,380

METHODS AND INTERMEDIATES FOR PREPARING JAK INHIBITORS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/013,380
Abstract

Improved processes and intermediates for preparing ruxolitinib, deuterated analogs of ruxolitinib, and other JAK inhibitors are disclosed.

Claims (84)

1 . A process for preparing a compound of Formula E:

the process comprising the step of reacting a compound of Formula B:

a compound of Formula C:

C or a mixture thereof

with formamidine or a salt thereof, or with a trialkyl orthoformate and an ammonium source, or with dimethylformamide dimethyl acetal and an ammonium source;

wherein R 1 is selected from H and a protecting group (PG), and wherein each R 3 is C 1 -C 10 alkyl, C 2 -C 10 alkenyl, aryl, or the two R 3 s, taken together with the oxygen atoms to which they are attached, form a 5-7-membered heterocyclic ring which may optionally be substituted.

2 . The process of claim 1 , wherein R 1 is H.

3 . The process of claim 1 , wherein R 1 is a protecting group.

4 . The process of claim 3 , wherein R 1 is a protecting group which is benzyl.

5 . The process of any one of claims 1 - 4 , wherein R 3 is methyl.

6 . The process of any one of claims 1 - 4 , wherein R 3 is ethyl.

7 . The process of any one of claims 1 - 6 , wherein the process comprises reacting a compound of Formula B with formamidine or a salt thereof, or with a trialkyl orthoformate, or with dimethylformamide dimethyl acetal.

8 . The process of any one of claims 1 - 6 , wherein the process comprises reacting a compound of Formula C with formamidine or a salt thereof, or with a trialkyl orthoformate, or with dimethylformamide dimethyl acetal.

9 . The process of any one of claims 1 - 8 , wherein the step of reacting is performed in a protic solvent.

10 . The process of claim 9 , wherein the protic solvent is methanol or n-butanol.

11 . The process of any one of claims 1 - 8 , wherein the step of reacting is performed in an aprotic solvent.

12 . The process of claim 11 , wherein the aprotic solvent is toluene.

13 . The process of any one of claims 1 - 12 , wherein the process comprises the step of reacting a compound of Formula B with formamidine or a salt thereof.

14 . The process of claim 13 , wherein the formamidine or salt thereof is formamidine acetate.

15 . The process of any one of claims 1 - 7 and 9 - 12 , wherein the process comprises the step of reacting a compound of Formula B with ammonium acetate and trimethyl orthoformate.

16 . A process for preparing a compound of Formula E:

the process comprising the step of reacting a compound of Formula A:

with formamidine or a salt thereof, or with an ammonium source and a trialkylorthoformate;

wherein R 1 is selected from H and a protecting group (PG), and wherein each R is C 1 -C 10 alkyl, C 2 -C 10 alkenyl, aryl, or the two R 3 s, taken together with the oxygen atoms to which they are attached, form a 5-7-membered heterocyclic ring which may optionally be substituted; and

the ammonium source is ammonia or an ammonium salt; provided that if each R 3 is ethyl, R 1 is not H.

17 . The process of claim 16 , wherein R 1 is H.

18 . The process of claim 16 , wherein R 1 is a protecting group.

19 . The process of claim 18 , wherein R 1 is a protecting group which is benzyl.

20 . The process of any one of claims 16 - 19 , wherein R 3 is methyl.

21 . The process of any one of claims 16 - 19 , wherein R 3 is ethyl.

22 . The process of claim 16 , wherein the ammonium source is an ammonium salt.

23 . The process of claim 22 , wherein the ammonium salt is ammonium acetate.

24 . The process of any one of claims 16 - 23 , wherein the step of reacting is performed in an aprotic solvent.

25 . The process of claim 24 , wherein the aprotic solvent is bis(2-methyoxyethyl)ether.

26 . The process of any one of claims 16 - 23 , wherein the step of reacting is performed in a protic solvent.

27 . The process of claim 26 , wherein the protic solvent is methanol.

28 . The process of any one of claims 16 - 27 , wherein the process comprises the step of reacting a compound of Formula A with formamidine or a salt thereof.

29 . The process of claim 28 , wherein formamidine or salt thereof is formamidine acetate.

30 . The process of any one of claims 16 - 28 , wherein the process comprises the step of reacting a compound of Formula A with ammonium acetate and a trialkylorthoformate.

31 . A process for preparing a compound of Formula 7:

the process comprising the step of reacting a compound of Formula 6a:

with formamidine or a salt thereof, or with trimethyl orthoformate, or with dimethylformamide dimethyl acetal;

wherein R 1 is selected from H or a protecting group (PG).

32 . The process of claim 31 , wherein R 1 is H.

33 . The process of claim 31 , wherein R 1 is a protecting group which is benzyl (Bn).

34 . A process for preparing a compound of Formula 7:

the process comprising the step of reacting a compound of Formula 5:

with formamidine or a salt thereof; or with an ammonium source and trialkyl orthoformate;

or with an ammonium source and dimethylformamide dimethylacetal;

wherein R 1 is selected from H or a protecting group (PG).

35 . The process of claim 34 , wherein R 1 is H.

36 . The process of claim 34 , wherein R 1 is a protecting group which is benzyl (Bn).

37 . A compound represented by the structure:

or a salt thereof

wherein Bn is a benzyl group.

38 . A process for preparing a compound of Formula 5:

the process comprising the step of reacting a compound of Formula 1:

with Compound 4

and a base;

wherein R 1 is selected from H or a protecting group (PG), and wherein R 2 is C 1 -C 4 alkyl.

39 . The process of claim 38 , wherein R 1 is H.

40 . The process of claim 38 , wherein R 1 is a protecting group which is benzyl (Bn).

41 . The process of any one of claims 38 - 40 , wherein R 2 is methyl.

42 . The process of any one of claims 38 - 40 , wherein R 2 is ethyl.

43 . The process of any one of claims 38 - 42 , wherein the base is NaHMDS.

44 . A process for preparing a compound of Formula 6a:

the process comprising the step of reacting a compound of Formula 5:

with an ammonium source;

wherein R 1 is selected from H or a protecting group (PG).

45 . The process of claim 44 , wherein R 1 is H.

46 . The process of claim 44 , wherein R 1 is a protecting group which is benzyl (Bn).

47 . The process of any one of claims 44 - 46 , wherein the ammonium source is selected from ammonium formate, ammonium chloride and ammonium acetate.

48 . A compound represented by the structure:

or a salt thereof

wherein Bn is a benzyl group.

49 . A compound represented by the structure:

or a salt thereof.

50 . A compound represented by the structure:

or a salt thereof.

51 . A compound represented by the structure:

or a salt thereof

wherein Bn is a benzyl group.

52 . A compound represented by the structure:

or a salt thereof.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 063818 FRAME 0961. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jul 20, 2023
From: CONCERT PHARMACEUTICALS, INC.
To: SUN PHARMACEUTICAL INDUSTRIES, INC.
Reel/Frame 064352/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2023
From: BAZINET, PATRICK; LEWIS, ROBERT S.; KARLA, MAHENDER; DONG, YONG
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 063850/0962 →
MERGER Recorded Jun 1, 2023
From: CONCERT PHARMACEUTICALS, INC.
To: SUN PHARMACEUTICALS INDUSTRIES, INC.
Reel/Frame 063818/0961 →